• APRO collaborates with Pivotal on three ISTs for genitourinary cancers pharmaceutical-technology
    July 12, 2018
    Spanish pharmaceutical cooperative Associació per a la Recerca Oncológia (APRO) has announced a partnership with European contract research organisation (CRO) Pivotal on three investigator sponsored trials (ISTs) of two drugs for patients with genitourina
PharmaSources Customer Service